Alembic Pharmaceuticals informs about company updates

06 Jun 2019 Evaluate

Alembic Pharmaceuticals has informed that the Company has received US Food & Drug Administration (USFDA) Approval for Carbidopa and Levodopa Extended-Release Tablets USP, 25 mg/100 mg and 50 mg/200 mg.

The above information is a part of company’s filings submitted to BSE.

Alembic Pharma Share Price

756.75 -5.80 (-0.76%)
27-Jan-2026 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1636.05
Dr. Reddys Lab 1236.15
Cipla 1313.20
Zydus Lifesciences 895.85
Lupin 2142.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×